| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |